DiogenX
Series ADiogenX raised €28M in a Series A round in May 2023. The company is based in Marseille, France. Investors in the round: AdBio partners, Boehringer Ingelheim Venture Fund, Eli lilly and company and 3 others. Data as of 4 Nov 2026.
Amount raised
€28M
€27,500,000
Native amount
27,500,000 EUR
Stage
Series A
series a
Investors
6
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €28M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
6 namedAdBio partnersBoehringer Ingelheim Venture FundEli lilly and companyJDRF T1D FundOmnes CapitalRoche Venture Fund
Date
May 2023
Round type
series a
Amount (EUR)
€28M